Novel perspectives on leptin in osteoarthritis: Focus on aging

Zimo Liu,Wenqing Xie,Hengzhen Li,Xu Liu,Yao Lu,Bangbao Lu,Zhenhan Deng,Yusheng Li
DOI: https://doi.org/10.1016/j.gendis.2023.101159
2023-11-04
Abstract:Osteoarthritis (OA) is a common chronic joint disease characterized by articular cartilage degeneration, subchondral sclerosis, synovitis, and osteophyte formation. OA is associated with disability and impaired quality of life, particularly among the elderly. Leptin, a 16-kD non-glycosylated protein encoded by the obese gene, is produced on a systemic and local basis in adipose tissue and the infrapatellar fat pad located in the knee. The metabolic mechanisms employed by leptin in OA development have been widely studied, with attention being paid to aging as a corroborative risk factor for OA. Hence, in this review, we have attempted to establish a potential link between leptin and OA, by focusing on aging-associated mechanisms and proposing leptin as a potential diagnostic and therapeutic target in aging-related mechanisms of OA that may provide fruitful guidance and emphasis for future research.
What problem does this paper attempt to address?